Back
BioCryst Pharmaceuticals, Inc. Vs. ViaSat, Inc. Industry Stock Comparison
Buy
59
BCRX
BioCryst Pharmaceuticals, Inc.
Last Price:
$9.03
Seasonality Move:
15.89%
Buy
55
VSAT
ViaSat, Inc.
Last Price:
$53.70
Seasonality Move:
6.9%
Buy
59
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
Is BioCryst Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $9.02. The Score for BCRX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
BCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
ViaSat, Inc. (VSAT)
is a Buy
Is ViaSat, Inc. a Buy, Sell or Hold?
-
The current ViaSat, Inc. [VSAT] share price is $53.69. The Score for VSAT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
VSAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCRX Stock Price Chart
What is BioCryst Pharmaceuticals, Inc.'s stock price today?
-
The BioCryst Pharmaceuticals, Inc. share price today is $9.02The current trend is moderately bearish and BCRX is experiencing selling pressure, which indicates risk of future bearish movement.
VSAT Stock Price Chart
What is ViaSat, Inc.'s stock price today?
-
The ViaSat, Inc. share price today is $53.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VSAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 52.42 | Buy |
| Chaikin Money Flow: | -4182320 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.57 - 9.55) | Sell |
| Bollinger Bands (100): | (6.71 - 8.57) | Buy |
VSAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.65 | Buy |
| Relative Strength Index (14 RSI): | 60.99 | Buy |
| Chaikin Money Flow: | 3174068 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.99 - 49.59) | Buy |
| Bollinger Bands (100): | (35.61 - 47.05) | Buy |
BCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.42 | Sell |
| 20-day SMA: | 9.16 | Sell |
| 50-day SMA: | 7.98 | Buy |
| 200-day SMA: | 7.88 | Buy |
| 8-day EMA: | 9.34 | Sell |
| 20-day EMA: | 9.09 | Sell |
| 50-day EMA: | 8.4 | Buy |
| 200-day EMA: | 7.91 | Buy |
VSAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.61 | Buy |
| 20-day SMA: | 47.5 | Buy |
| 50-day SMA: | 46.13 | Buy |
| 200-day SMA: | 33.78 | Buy |
| 8-day EMA: | 48.06 | Buy |
| 20-day EMA: | 47.5 | Buy |
| 50-day EMA: | 45.6 | Buy |
| 200-day EMA: | 35.16 | Buy |
BioCryst Pharmaceuticals, Inc. Earnings Growth & BCRX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.32 per share.
ViaSat, Inc. Earnings Growth & VSAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $1.05 per share, and a decrease next year of $0.65 per share.
BioCryst Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ViaSat, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||